ReleaseWire Connect

The Croatia Tourism Report looks at the sector's recent performance and considers the long-term potential of the industry. After a recovery in 2010, foreign tourist arrivals grew by a solid 9.0% in 2011, while domestic tourism picked up but remained relatively weak. This year, BMI continues to expect a sharp slowdown in the growth of visitor arrivals, unchanged at less than 3%, given the bleak outlook for the eurozone, which is the country's key source region.

BMI View: The impressive performance of Pakistan across the key commodities of cotton, rice and corn, all of which are grown with the export market in mind, compared with the relative under performance of wheat and sugar, the production of which is largely absorbed by domestic consumption, suggests that agribusiness in the country does best when responding to international markets.

BMI's Spain Defence & Security Report for Q4 2012 examines the country's strategic posture, its defence industry and its defence procurement plans.

The Egypt Real Estate report examines the Commercial Office, Retail, Industrial and Construction segments in the context of a market, which in spite of its long-term potential, continues to be susceptible to instability and which will be characterized by the aftershocks of the Arab Spring in the short-to medium term.

Core Views We expect Tanzania's economy to recover in 2013 and forecast 7.5% growth, up from an expected 5.5% in 2012. Underpinning our forecasts is an expectation that falling inflation and recovering power generation will lead to an improvement in the domestic macroeconomic climate, while an increase in gold production and healthy economic outlooks for Tanzania's neighbours will boost the external sector as well. Inflation will decline only very slowly over the course of 2012 as falling food prices and improving base effects are partially offset by high energy prices. Although our relatively high end-2012 inflation forecast of 12.6% is largely driven by supply-side considerations, we expect that the Bank of Tanzania will keep the reins tight on monetary policy to stave off the prospect of demand-pull inflation and to support the currency. Defections from Chama Cha Mapinduzi (CCM) are a clear indication that all is not well in the ruling party in Tanzania. A looming succession battle and a rise in popularity of opposition Chama Cha Demokrasia Na Maendeleo will make life difficult for CCM leadership as it seeks to reverse the party's decline. Major Forecast Changes Revisions to 2011 data mean that Tanzania will post an even larger current account deficit in 2012 than we had previously forecast. A high oil import bill, strong demand for capital goods and relatively weak growth in gold exports will see the shortfall expand to US$4.21bn in 2012, from an estimated US$3.43bn in 2011. We believe things will improve from 2013, however, as new gold production and lower demand for and prices of oil lead to a narrowing of the shortfall to US$4.18bn that year. Key Risks To Outlook The major risk to our outlook comes from the weather. Poor rains would not only exacerbate tight food supplies (food price inflation has been the major driver of rapidly rising inflation) but would also once again hamper hydroelectricity production, raising costs for businesses and, by extension, consumers. The country's infrastructure deficit is another concern; a failure to make significant progress would likely hold the economy back from reaching its significant potential.

Passenger car sales in the Czech Republic increased 5% y-o-y, to 105,391 units, in the first seven months of 2012, according to the Czech Automotive Industry Association. BMI, however, maintains its forecast for 3% growth in the sector in 2012, as a number of factors affecting consumer sentiment and purchasing power lead us to believe that passenger car sales will not be able to maintain the strong rate of growth observed in the first seven months of the year.

Global Markets Direct's, 'AIDS - Related Cancer - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for AIDS - Related Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for AIDS - Related Cancer. AIDS - Related Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Sepsis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Sepsis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Sepsis. Sepsis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Anal Cancer - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Anal Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Anal Cancer. Anal Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Market Direct's pharmaceuticals report, "Sequella, Inc. - Product Pipeline Review - 2012" provides data on the Sequella, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.